A New Decade for Continuous Manufacturing: Current Landscape and Future Opportunities
iSpeak Blog
The 2020 ISPE Continuous Manufacturing Virtual Workshop delivered engaging presentations and case studies on cutting-edge topics with many opportunities to gain insights from top industry professionals. Check out the content below to get insights from the conference.
Hear from keynote presenter John Erickson, PhD, Senior Fellow, NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals, as he shares a 10-year vision to solve the biggest manufacturing problems during the session “A New Decade for Continuous Manufacturing” at the 2020 ISPE Continuous Manufacturing Virtual Workshop.
Cheryl Essex, Head of Microbiological Control for Biologic Drugs, Sanofi, addressed this during her presentation “Modern Microbiological Monitoring of Continuous Processing.” Watch now to get a snippet of her response during the 2020 ISPE Continuous Manufacturing Virtual Workshop.
Hear from Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca, and Mark Brower, Principal Scientist, Merck, as they answer questions at the end of the session "Current Status on CM for Biologics: Development to Clinical" at the 2020 ISPE Continuous Manufacturing Virtual Workshop.
Watch Now: Jeroen Geens, PhD, Engineering Technical Director, New Platforms, The Janssen Pharmaceutical Companies of Johnson & Johnson, gave attendees of the 2020 ISPE Continuous Manufacturing Virtual Workshop a look into Janssen’s CM-strategy during the session “Success Stories from Small Molecule Drug Product.”
Watch Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca, give his perspective during the session “Current Status on CM for Biologics: Development to Clinical” at the 2020 ISPE Continuous Manufacturing Virtual Workshop.